Section Arrow
Quote
CPHI.NYSE-M
- China Pharma Holdings Inc
Quotes are at least 15-min delayed:2025/07/04 04:32 EDT
Last
 1.84
+0.095 (+5.44%)
Day High 
1.85 
Prev. Close
1.745 
1-M High
2.05 
Volume 
20.95K 
Bid
1.65
Ask
1.88
Day Low
1.74 
Open
1.74 
1-M Low
1.46 
Market Cap 
5.69M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.74 
20-SMA 1.69 
50-SMA 1.87 
52-W High 3.35 
52-W Low 1.2 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-2.22/--
Enterprise Value
7.08M
Balance Sheet
Book Value Per Share
2.14
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
4.53M
Operating Revenue Per Share
2.44
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands0.5387+0.0535+11.03%-- 
RGCRegencell Bioscience Holdings Limited22.99+12.63+121.91%-- 
CGCCanopy Growth Corp1.28+0.09+7.56%-- 
IXHLIncannex Healthcare0.2094+0.0025+1.21%-- 
HLNHaleon plc10.25-0.01-0.10%23.95PE
Quotes are at least 15-min delayed：2025/07/04 04:32 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.